Aug 2024 – Present · 1 yr 9 mos · Hyderabad, Telangana, India

• Design and implement integrated market access strategies to optimize product pricing, reimbursement outcomes, and patient access across priority markets, working in close alignment with key internal and external stakeholders.
• Partner cross-functionally across medical, regulatory, commercial, and policy teams to ensure market access strategies are embedded early in the asset lifecycle and are fully synchronized with broader product development goals.
• Craft compelling payer value propositions and evidence-based value stories tailored to national and regional HTA requirements, clearly articulating clinical, economic, and societal value to health authorities and reimbursement bodies.
• Conduct comprehensive market intelligence and landscape assessments to monitor evolving healthcare policies, identify unmet payer needs, and track competitor access strategies, leveraging insights to inform forward-looking access plans.
• Lead strategic planning for HTA and reimbursement submissions, ensuring robust evidence generation, accurate pricing strategy, and alignment with local payer expectations to maximize approval potential and commercial uptake.
• Drive cross-functional project management for access deliverables, ensuring on-time, high-quality execution of pricing files, HEOR dossiers, negotiation materials, and payer engagement strategies.
• Champion early access and launch planning initiatives, ensuring integration of market-specific insights into product launch roadmaps, including budget impact modeling, ICER thresholds, and comparator positioning.
• Proactively engage with external stakeholders (e.g., payers, HTA agencies, KOLs) to co-create value frameworks, address barriers to access, and maintain readiness for evolving evidence and pricing discussions.
• Continuously refine access strategy based on real-world data (RWD), HTA feedback, and policy shifts, ensuring sustained access and reimbursement for new indications and label expansions.

Apr 2022 – Aug 2024 · 2 yrs 4 mos · Hyderabad, Telangana, India

• HTA Evaluations - Determine the most important factors that influence payer decisions. Identify access impediments and design an access strategy and case studies in collaboration with countries and a global cross-functional team.
• Project management - collaborate closely with regions and countries to determine access requirements as part of an integrated evidence plan for launch brands.
• RWE role in HTA decision making and identify the submissions. Identify key drivers for price and access for payer stakeholders and address challenges by product and portfolio level in key markets and segments.
• Conduct price optimization modelling analysis for launch brands and referencing pricing impact analysis ,optimize and maintain launch sequence/international pricing modelling and process (incl. collecting referencing rules
• Understanding the policy environment in country and develop strategies in line with the changing polices for market access and reimbursements for pharmaceutical and medtech products

Aug 2019 – Mar 2022 · 2 yrs 7 mos · Hyderabad, Telangana, India

• Provide robust pricing analysis and recommendation to global pricing team and senior management, and maintain the strategic pricing foundation/insights house
• Drive pilot projects, track and monitor progress and ensure future stabilization and also ensure superior customer satisfaction by delivering high end quality support to Global and Regional team
• Conduct price optimization modelling analysis for launch brands and referencing pricing impact analysis ,optimize and maintain launch sequence/international pricing modelling and process (incl. collecting referencing rules, conducting trainings and improving features of the tool)
• Identify key drivers for price and access for payer stakeholders and address challenges by product and portfolio level in key markets and segments.
• Understanding the policy environment in country and develop strategies in line with the changing polices for market access and reimbursements for pharmaceutical and medtech products
• Understand key market access related risks and study of healthcare systems to provide information related to country-specific reimbursement requirements and key policy changes
• Partner with Business Teams of operating units towards accelerated access and help removing administrative access barriers.